Skip to Content
Merck
All Photos(1)

Key Documents

25107

Sigma-Aldrich

Potassium citrate tribasic monohydrate

meets analytical specification of Ph. Eur., BP, FCC, E332, 99-100.5% (calc with ref. to anhyd. subst.)

Synonym(s):

Citric acid tripotassium salt, Tripotassium citrate

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
HOC(COOK)(CH2COOK)2 · H2O
CAS Number:
Molecular Weight:
324.41
Beilstein:
3924344
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.21

Quality Level

Assay

99-100.5% (calc with ref. to anhyd. subst.)

form

powder or crystals

quality

meets analytical specification of Ph. Eur., BP, FCC, E332

impurities

≤0.0005% heavy metals (as Pb)
4-6% water (Karl Fischer)

loss

3-6 loss on drying, 180°C

pH

7-9 (20 °C, 5%)

mp

275 °C (dec.) (lit.)

solubility

glycerol: soluble 1 gm in 2.5 ml
water: soluble 1 gm in 0.65 ml
alcohol: insoluble

anion traces

chloride (Cl-): ≤30 mg/kg
oxalate (as oxalic acid): ≤100 mg/kg
sulfate (SO42-): ≤50 mg/kg

cation traces

As: ≤1 mg/kg
Cu: ≤10 mg/kg
Fe: ≤10 mg/kg
Hg: ≤1 mg/kg
Na: ≤3000 mg/kg
Pb: ≤1 mg/kg
Zn: ≤10 mg/kg

suitability

in accordance for appearance of solution
passes test for reaction against H2SO4

application(s)

pharmaceutical (small molecule)

SMILES string

O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

InChI

1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3

InChI key

PJAHUDTUZRZBKM-UHFFFAOYSA-K

Looking for similar products? Visit Product Comparison Guide

Application

Potassium citrate tribasic monohydrate has been used for preparing citrate-supplemented water for feeding the Car5A, Car5B, and DKO breeding pairs of mice. Citrate supplementation enhances the perinatal death in mice. It is a citrate-based salt used as a phase constituent for characterizing ionic-liquid-based aqueous biphasic systems (ABS) and as a buffering agent.

Biochem/physiol Actions

Potassium citrate tribasic monohydrate is the potassium salt of citric acid. It enhances the bone density hence used in the treatment of osteoporosis. Additionally, it neutralizes the protein-induced metabolic acidosis.

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

Antonia Fabris et al.
Clinical journal of the American Society of Nephrology : CJASN, 4(12), 1974-1979 (2009-10-08)
In medullary sponge kidney (MSK)-a common malformative renal condition in patients with calcium nephrolithiasis-hypercalciuria, incomplete distal renal tubular acidosis, and hypocitraturia are common. Clinical conditions with concomitant hypercalciuria and/or incomplete distal renal tubular acidosis are almost invariably associated with bone
Good's buffers as a basis for developing self-buffering and biocompatible ionic liquids for biological research.
M. Taha, F. e Silva, M. V. Quental et al.
Green Chemistry (2014)
Characterization of aqueous biphasic systems composed of ionic liquids and a citrate-based biodegradable salt.
Helena Passos
Biochemical Engineering Journal, 67, 68- 76 (2012)
Julie Mardon et al.
The Journal of nutrition, 138(4), 718-724 (2008-03-22)
High dietary protein intake generates endogenous acid production, which may adversely affect bone health. Alkaline potassium citrate (Kcit)(2) may contribute to the neutralization of the protein-induced metabolic acidosis. We investigated the impact of 2 levels of protein intake and Kcit
Donna J Claes et al.
Pediatric nephrology (Berlin, Germany), 27(11), 2031-2038 (2012-01-28)
Cystinuria is a relatively uncommon cause of pediatric stone disease, but has significant morbidity if not properly controlled because of its significant stone recurrence rate. Cystinuria is caused by the inability of the renal tubules to reabsorb filtered cystine, which

Related Content

Find solutions for bulk production, custom packaging, and personalized chemical services to meet your unique research, development, and manufacturing requirements in your industries, including pharmaceuticals, biotechnology, and research institutions.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service